Ä¿¹Â´ÏƼ

¾¾¾ÆÀ̹ÙÀÌ¿À´Â ¹ÏÀ½°ú ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î
±Í»çÀÇ ±¹³», ÇØ¿ÜÁøÃâÀÇ ÆÄÆ®³Ê°¡ µÇ°Ú½À´Ï´Ù.

Ä¿¹Â´ÏƼ

  • Ȩ
  • Ä¿¹Â´ÏƼ
  • ÀÚ·á½Ç

ÀÚ·á½Ç

Á¦¸ñ Registration (EU) Reference.
ÀÛ¼ºÀÚ °ü¸®ÀÚ
ÀÛ¼ºÀÏÀÚ 2025-05-26
Á¶È¸¼ö 38


À¯·´ÁøÃâµî·ÏÀ» À§ÇÑ Àú·ÅÇÑ ºñ¿ëÇÁ·Î±×·¥ÀÌ ÀÖ½À´Ï´Ù.


1) 30 Countries(27EU MS +3EEA)
  * Market Size , and % of the global market: Drugs in 2024: ~300 Billion USD, ~20%
                                                   Med Tech in 2023 : ~Euro 160 billion, ~26%
2) Drugs: MA, compliance to GxP, EU LR, QP, QPP
           Approval :EMA (CP,all 30 countries) or
           NCA (DCP)
3) MedTech: CE mark, ISO 13485, QMS,EU AR, PRRC


4) Medicinal Products
   (1)  small molecule drugs
   (2)Biologics
   (3)ATMPS
   (4)orphan medicine products
   (5) Radiopharmaceuticals
   (6) Combination products


5) EU registration fee : Á¦Á¶ÀÚ°¡ Áß¼Ò±â¾÷¿¡ ÇØ´çµÉ½Ã¿¡ ´ç»ç¸¦ ÅëÇØ ºñ¿ëÀ» ÁÙÀÌ´Â ¹æ¹ýÀÌÀÖ½À´Ï´Ù.
6)  ±×¿ÜÀÇ Á¦Ç°¿¡ µû¶ó  EMA ½Å¼Ó½ÂÀεîÀÇ »ó´ãµµ °¡´ÉÇÕ´Ï´Ù.


7) °³¹ßÁ¦Ç°ÀÇ ÀûÀÀÁõ¿¡ µû¸¥ ÇØ¿ÜÆÇ¸Å°ü·Ã¹× ÆÇ±Ç¾÷¹«µî ¾÷¹«µµ °¡´ÉÇÕ´Ï´Ù.

 ¹®ÀÇ»çÇ×Àº À̸ÞÀÏ·Î ¹®ÀÇÁÖ½Ã¸é  
 Á¤º¸ È®ÀÎÈÄ ´äº¯µå¸®°Ú½À´Ï´Ù.
 
÷ºÎÆÄÀÏ
Drug development steps.jpg ´Ù¿î·Îµå : 13